Delivering the benefits of genomic data reanalysis for diagnosis equitably and at scale

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Welland, M. J. et al. Automated reanalysis of genomic data for rare disease diagnostics at scale. Nat. Med. https://doi.org/10.1038/s41591-026-04477-5 (2026).